DRKS00008174已完成不适用
Vedolizumab register in patients with inflammatory bowel disease in Germany - VEDOibd
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 339
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •IBD ( inflammatory bowel disease) and Vedolizumab therapy
排除标准
- •age >18 years
研究者
相似试验
已完成
不适用
Prospective evaluation of vedolizumab-effects in patients with inflammatory bowel diseasesulcerative colitis and Crohn's diseaseJPRN-UMIN000039916Saitama Medical Center, Saitama Medical University50
已完成
不适用
Vedolizumab Study with Inflammatory Bowel Disease Patients in GermanyK50K51Crohn disease [regional enteritis]Ulcerative colitisDRKS00013251CED Service GmbH1,280
撤回
不适用
Efficacy and Safety of vedolizumab in biologic-naïve Korean patients with moderate to severe inflammatory bowel diseaseDiseases of the digestive systemKCT0006087Yonsei University Health System, Severance Hospital60
招募中
不适用
Prospective evaluation of vedolizumab-effects and safety in patients with inflammatory bowel diseases (VED IBD Cohort Study)JPRN-UMIN000040175Saitama Medical Center, Saitama Medical University50
暂停
不适用
Pharmacokinetics and efficacy of Vedolizumab in inflammatory bowel diseasesulcerative colitis and Crohn's diseaseJPRN-UMIN000045425Shiga University of Medical Science50